Philip Beer

VP, Head of Researchand Translational Medicine

Philip Beer is a physician scientist with expertise in drug development and biomarker discovery. He followed his initial training as a haematologist with 8 years’ research in Cambridge and Vancouver, focused on understanding genotype-phenotype correlations in haematological cancers and developing improved preclinical models of leukaemia. Since then, Philip has worked cross-sector in academic, healthcare and biotech roles with a unified goal of accelerating oncology drug development and ensuring that each patient receives the most suitable therapy.

LinkedIN Profile
Share this page